https://radiologykey.com/essential-equipment-puncture-needles/

Microneedle technology marks a revolutionary breakthrough in the field of drug delivery. Consisting of micron-sized needle arrays, these devices pierce the outermost stratum corneum of the skin without penetrating deep enough to irritate peripheral nerve endings, enabling genuinely pain-free injections. This innovative technique resolves key drawbacks of conventional hypodermic injections including patients' needle phobia, procedural pain and reliance on trained medical staff, opening new avenues for self-administration and telemedicine.

Based on working mechanisms, microneedles are categorized into five major types: solid, coated, dissolvable, hollow and hydrogel-based variants. Solid microneedles create microchannels in the skin prior to topical drug application; drug-coated microneedles carry therapeutics on their surface and release payloads immediately upon skin penetration; dissolvable microneedles fabricated from biodegradable biomaterials encapsulate drugs and dissolve in interstitial fluid post insertion to release active ingredients; hollow microneedles function like miniature syringes for direct infusion of liquid formulations. These diversified designs accommodate the physicochemical properties and therapeutic requirements of varied pharmaceuticals such as macromolecular biologics, vaccines and hormones.

Microneedling has demonstrated remarkable translational potential in clinical practice, with insulin administration for diabetic patients standing as a flagship application. Conventional insulin requires 1 to 4 daily injections, which commonly induce injection-site lipohypertrophy and persistent soreness following long-term use. In contrast, microneedle patches facilitate sustained, steady transdermal insulin absorption and greatly improve medication adherence. Research data proves microneedle-delivered insulin yields more stable blood drug levels, lower hypoglycemia risks and superior patient satisfaction, with multiple insulin microneedle candidates now under clinical trials.

Vaccination represents another vital application arena for microneedles. Traditional injectable vaccines require cold-chain transportation and professional inoculation, hindering popularization in resource-limited regions. Microneedle vaccine patches remain thermostable at ambient temperature and can be administered by untrained personnel or even via self-vaccination, substantially boosting vaccine accessibility. Promising preclinical outcomes have been achieved for microneedle formulations against influenza, measles and HPV vaccines. Particularly during the COVID-19 pandemic, microneedle vaccination garnered widespread attention for its user-friendly features. Preliminary evidence indicates microneedle-delivered vaccines elicit comparable immune responses to conventional intramuscular shots at potentially reduced antigen dosages.

Beyond macromolecular drugs and vaccines, microneedles deliver outstanding performance in chronic disease management. Long-acting sustained release via microneedles is achievable for levodopa for Parkinson's disease, parathyroid hormone for osteoporosis and contraceptive steroids to enhance therapeutic efficacy. For pain management, microneedles locally deliver anesthetics and analgesics to produce targeted, prolonged pain relief while minimizing systemic adverse reactions.

Microneedles have also pioneered innovative localized treatment for dermatological disorders. They bypass the intact epidermal barrier to enhance targeted drug delivery for psoriasis, eczema and cutaneous T-cell lymphoma directly onto lesional tissues. When combined with photothermal therapy or electroporation, stimulus-responsive smart microneedles achieve on-demand adjustable drug release that adapts automatically to evolving disease conditions.

Looking ahead, driven by advances in material science, micro-nano fabrication and the Internet of Medical Things, microneedles will evolve toward intelligent and multi-functional platforms. Biosensor-integrated microneedles monitor real-time blood glucose and circulating drug concentrations to automatically regulate dosage via closed-loop feedback systems; multi-layer stacked microneedles sequentially release multiple medications to mimic endogenous physiological secretion rhythms; flexible-electronics-coupled microneedle systems support wireless programming and data transmission, ultimately realizing customized precision medicine.